MedWatch

Analyst surprised by Lundbeck announcement

The recent downgrading of expectations in Lundbeck is largely due to factors which no one could have anticipated when expectations were set following the patent cliff. But could the pharmaceutical group have informed investors about factors affecting the bottom line earlier on, one analyst wonders?

It came as a great surprise to Sydbank analyst Søren Løntoft Hansen when Lundbeck lowered expectations for the financial years 2013 and 2014 this Wednesday morning.

But the news did not just induce a sense of surprise, but even a sense of astonishment for the analyst, who believes that Lundbeck could have announced some of the negative effects on its results earlier in the process.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier